12 Jan Becker’s Hospital Review: HHS nominee Alex Azar grilled on drug prices during Senate hearing
Posted on January 12, 2018
“High drug prices were a hot topic of discussion at HHS secretary nominee Alex Azar’s Senate confirmation hearing Tuesday, reports USA Today.
Here are four things to know about Mr. Azar’s stance on drug prices:
1. He agrees drug prices are too high. Sen. Ron Wyden, D-Ore., cited numerous drugs that more than doubled in price while Mr. Azar served as a drug executive at Eli Lilly. When asked if he ever lowered prices on any drugs during his tenure at the company, Mr. Azar said, “Drug prices are too high. I said that when I was at Lilly.”
